{
    "root": "303a8d17-68c8-fd01-e063-6394a90a4fd8",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Sildenafil",
    "value": "20250313",
    "ingredients": [
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "ANHYDROUS DIBASIC CALCIUM PHOSPHATE",
            "code": "L11K75P92J"
        },
        {
            "name": "HYPROMELLOSE 2910 (15 MPA.S)",
            "code": "36SFW2JZ0W"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "TRIACETIN",
            "code": "XHX3C3X673"
        },
        {
            "name": "SILDENAFIL CITRATE",
            "code": "BW9B0ZE037"
        }
    ],
    "indications": "adults sildenafil tablets indicated treatment pulmonary arterial hypertension ( pah ) ( world health organization [ ] group ) adults improve exercise ability delay worsening [ ( 14 ) ] . pediatric information approved viatris specialty llc 's , revatio ( sildenafil ) tablets . however , due viatris specialty llc 's marketing exclusivity rights , product labeled information .",
    "contraindications": "adults : 20 mg three times day . ( 2.1 ) injection ( adults ) : 10 mg three times day administered intravenous bolus injection . ( 2.1 )",
    "warningsAndPrecautions": "sildenafil tablets usp , 20 mgare white colored , round shape , biconvex , film-coated tablets , debossed \u2018 \u2019 one side \u2018 27 \u2019 side . bottles 10 ndc 43063-982-10 bottles 30 ndc 43063-982-30 recommended storage sildenafil tablets usp : store 20\u00b0 25\u00b0c ( 68\u00b0 77\u00b0f ) [ usp controlled room temperature ] .",
    "adverseReactions": "sildenafil tablets contraindicated patients : concomitant organic nitrates form , either regularly intermittently , greater risk hypotension [ ( 5.1 ) ] . concomitant riociguat , guanylate cyclase stimulator . phosphodiesterase-5 ( pde-5 ) inhibitors , including sildenafil , may potentiate hypotensive effects riociguat . known hypersensitivity sildenafil component tablet , injection , oral suspension . hypersensitivity , including anaphylactic reaction , anaphylactic shock anaphylactoid reaction , reported association sildenafil .",
    "indications_original": "Adults\n                  \n                  \n                  Sildenafil tablets are indicated for the treatment of pulmonary arterial hypertension (PAH) (World Health Organization [WHO] Group I) in adults to improve exercise ability and delay clinical worsening\n \n  [see\n  \n   Clinical Studies (14)]\n \n  . \n  \n                     \n                          Pediatric use information is approved for Viatris Specialty LLC's, REVATIO (sildenafil) tablets. However, due to Viatris Specialty LLC's marketing exclusivity rights, this drug product is not labeled with that information\n  .",
    "contraindications_original": "Adults: 20 mg three times a day.\u00a0( 2.1 ) Injection (Adults): 10 mg three times a day administered as an intravenous bolus injection. ( 2.1 )",
    "warningsAndPrecautions_original": "Sildenafil Tablets USP, 20 mgare white colored, round shape, biconvex, film-coated\u00a0 tablets, debossed with \u2018T\u2019 on one side and \u201827\u2019 on other side. \n  \n                       Bottles of 10\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NDC 43063-982-10 \n  \n                       Bottles of 30\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NDC 43063-982-30 \n  \n                       Recommended Storage for Sildenafil Tablets USP: Store at 20\u00b0 to 25\u00b0C (68\u00b0 to 77\u00b0F) [see USP Controlled Room Temperature].",
    "adverseReactions_original": "Sildenafil\u00a0tablets are\u00a0contraindicated in patients with:\n                  \n                  \n                     Concomitant use of organic nitrates in any form, either regularly or intermittently, because of the greater risk of hypotension\n  \n   [see\n   \n    Warnings and Precautions (5.1)]\n  \n   .\n \n  \n                     Concomitant use of riociguat, a guanylate cyclase stimulator.\u00a0Phosphodiesterase-5 (PDE-5) inhibitors, including sildenafil, may potentiate the hypotensive effects of riociguat.\n                     Known hypersensitivity to sildenafil or any component of the tablet, injection, or oral suspension.\u00a0Hypersensitivity, including anaphylactic reaction, anaphylactic shock and anaphylactoid reaction, has been reported in association with the use of sildenafil."
}